Tumor-normal sequencing reveals novel TP53 germline and clinically actionable somatic mutations in Nigerian breast cancer patientsAbimbola F. Onyia, Ebenezer S. Nkom, Nwamaka Lasebikan et al.|Cancer Genetics|2025Cited by 2
<sup>1</sup> H NMR-Based Plasma Metabolomics and Machine Learning Reveal Distinct Metabolic Signatures of Breast Cancer in Nigerian WomenAbimbola F. Onyia, Solomon O. Rotimi, Olutola E. Olasehinde et al.|Journal of Proteome Research|2026Cited by 0